Liposomes containing glucosyl ceramide specifically bind T4 bacteriophage: a self-assembling nanocarrier formulation

References

• Alving, C. R. (1993) Lipopolysaccharide, lipid A, and liposomes containing lipid A as immunologic adjuvants. Immunobiology 187(3-5):430–446.
   PubMed Web of Science ®Google Scholar
• Alving CR. (2002). Design and selection of vaccine adjuvants: animal models and human trials. Vaccine 20(Suppl 3):S56–S64.
   Google Scholar
• Alving, C. R., Rao, M. (2008). Lipid A and liposomes containing lipid A as antigens and adjuvants. Vaccine 26:3036–3045.
   PubMed Web of Science ®Google Scholar
• Beck, Z., Karasavvas, N., Tong, J., Matyas, G. R., Rao, M., Alving, C. R. (2007). Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate. Biochem Biophys Res Commun 354:747–751.
   PubMed Web of Science ®Google Scholar
• Dawes, J. (1975). Characterisation of the bacteriophage T4 receptor site. Nature 256:127–128.
   PubMed Web of Science ®Google Scholar
• Fries, L. F., Gordon, D. M., Richards, R. L., Egan, J. E., Hollingdale, M. R., Gross, M., et al. (1992). Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy. Proc Natl Acad Sci U S A 89:358–362.
   PubMed Web of Science ®Google Scholar
• Garcon, N., Goldman, M. (2009). Boosting vaccine power. Sci Am 301:72–79.
   PubMed Web of Science ®Google Scholar
• Garcon, N., Chomez, P., Van Mechelen, M. (2007). GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements, and perspectives. Exp Rev Vaccines 6:723–739.
   PubMed Web of Science ®Google Scholar
• Guy, B. (2007). The perfect mix: recent progress in adjuvant research. Nat Rev Microbiol 5:505–517.
   PubMed Web of Science ®Google Scholar
• Harandi, A. M., Davies, G., Olesen, O. F. (2009). Vaccine adjuvants: scientific challenges and strategic initiatives. Exp Rev Vaccines 8:293–298.
   PubMed Web of Science ®Google Scholar
• Horton, R. M., Hunt, H. D., Ho, S. N., Pullen, J. K., Pease, L. R. (1989). Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77(1):61–68.
   PubMed Web of Science ®Google Scholar
• Leiman, P. G., Shneider, M. M., Kostyuchenko, V. A., Chipman, P. R., Mesyanzhinov, V. V., Rossmann, M. G. (2003) Structure and location of gene product 8 in the bacteriophage T4 baseplate. J Mol Biol. 328(4):821–833.
   PubMed Web of Science ®Google Scholar
• Muster, T., Steindl, F., Purtscher, M., Trkola, A., Klima, A., Himmler, G., et al. (1993). A conserved neutralizing epitope on gp41 of human immunodeficiency virus type 1. J Virol 67:6642–6647
   PubMed Web of Science ®Google Scholar
• Prehm, P., Jann, B., Jann, K., Schmidt, G., Stirm, S. (1976) On a bacteriophage T3 and T4 receptor region within the cell wall lipopolysaccharide of Escherichia coli B. J Mol Biol 101:277–281.
   PubMed Web of Science ®Google Scholar
• Reed, S. G., Bertholet, S., Coler, R. N., Friede, M. (2009). New horizons in adjuvants for vaccine development. Trends Immunol 30:23–32.
   PubMed Web of Science ®Google Scholar
• Rao, V. B., Mitchell, M. S. (2001). The N-terminal ATPase site in the large terminase protein gp17 is critically required for DNA packaging in bacteriophage T4. J Mol Biol 314:401–411.
   PubMed Web of Science ®Google Scholar
• Rao, M., Matyas, G. R., Vancott, T. C., Birx, D. L., Alving, C. R. (2004). Immunostimulatory CpG motifs induce CTL responses to HIV type I oligomeric gp140 envelope protein. Immunol Cell Biol 82:523–530.
   PubMed Web of Science ®Google Scholar
• Rao, M., Peachman, K. K., Li, Q., Matyas, G. R., Shivachandra, S. B., Borschel, R., et al. (2011). Highly effective generic adjuvant systems for orphan or poverty-related vaccines. Vaccine 29:873–877.
   PubMed Web of Science ®Google Scholar
• Sathaliyawala, T., Rao, M., Maclean, D. M., Birx, D. L., Alving, C. R., Rao, V. B. (2006). Assembly of human immunodeficiency virus (HIV) antigens on bacteriophage T4: a novel in vitro approach to construct multicomponent HIV vaccines. J Virol 80:7688–7698.
   PubMed Web of Science ®Google Scholar
• Shivachandra, S. B., Rao, M., Janosi, L., Sathaliyawala, T., Matyas, G. R., Alving, C. R., et al. (2006). In vitro binding of anthrax protective antigen on bacteriophage T4 capsid surface through Hoc-capsid interactions: a strategy for efficient display of large full-length proteins. Virology 345:190–198.
   PubMed Web of Science ®Google Scholar
• Shivachandra, S. B., Li, Q., Peachman, K. K., Matyas, G. R., Leppla, S. H., Alving, C. R., et al. (2007). Multicomponent anthrax toxin display and delivery using bacteriophage T4. Vaccine 25:1225–1235.
   PubMed Web of Science ®Google Scholar
• Wassef, N. M., Alving, C. R., Richards, R. L. (1994). Liposomes as carriers for vaccines. Immunomethods 4(3):217–222.
   PubMedGoogle Scholar
• Yu, F., Mizushima, S. (1982). Roles of lipopolysaccharide and outer membrane protein OmpC of Escherichia coli K 12 in the receptor function for bacteriophage T4. J Bacteriol 151:718–722.
   PubMed Web of Science ®Google Scholar
• Zwick, M. B., Labrijn, A. F., Wang, M., Spenlehauer, C., Saphire, E. O., Binley, J. M., et al. (2001). Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41. J Virol 75:10892–10905.
   PubMed Web of Science ®Google Scholar